Zydus Lifesciences Ltd 2023 AR2
The report highlights Zydus Lifesciences Limited's financial and operational performance for the fiscal year 2022-23, showcasing a 14% revenue growth to ₹172.4 billion. The company made significant progress in its ESG initiatives, achieving a 20% reduction in greenhouse gas emission intensity and a 150% increase in renewable energy utilization. Zydus also advanced its innovation pipeline with key clinical trials for its NCEs, Saroglitazar and Desidustat, and launched the indigenously developed MMR vaccine in India. Additionally, the company's CSR program supported the Zydus Medical College and Hospital in Dahod, treating over 414,000 patients during the year.
Company: Zydus Lifesciences Ltd
Sector: Health Care
Country: India
Year: 2023
Type: AR2
Pages: 372
Zydus Lifesciences Ltd
Annual Report
The report highlights Zydus Lifesciences Limited's financial and operational performance for the fiscal year 2022-23, showcasing a 14% revenue growth to ₹172.4 billion. The company made significant progress in its ESG initiatives, achieving a 20% reduction in greenhouse gas emission intensity and a 150% increase in renewable energy utilization. Zydus also advanced its innovation pipeline with key clinical trials for its NCEs, Saroglitazar and Desidustat, and launched the indigenously developed MMR vaccine in India. Additionally, the company's CSR program supported the Zydus Medical College and Hospital in Dahod, treating over 414,000 patients during the year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees